Emblation
Kelly Findlay has extensive experience in regulatory affairs and operations within the medical and healthcare sectors. Currently serving as a Regulatory Specialist and Operations Manager at Emblation Limited since July 2014, Kelly has also held positions as a Regulatory Affairs Officer at Quotient Limited and Axis-Shield Diagnostics, and as a Document Control/Change Analyst at Spacelabs Healthcare. Previous roles include QA Auditor at BioReliance and Document Technician at Microsulis Medical Ltd. Kelly's career spans from 2005, beginning with a foundation in quality assurance and document management. Education was completed at Blairgowrie High School from 1991 to 1997.
This person is not in any teams
This person is not in any offices
Emblation
Emblation is a global leader in medical microwave technology, with a focus on radical innovation in the treatment of HPV infections, dermatology, cardiology, and oncology. Swift® – Award-winning treatments in Podiatry and Dermatology Launched in 2016, Swift® is one of the fastest growing treatments in Podiatry today - now available in the UK, Canada, Australia, and the USA. Find out more by visiting www.treatwithswift.com. Rapid Product Development Service (www.emblationmicrowave.com) Are you interested in using our platform for your clinical applications? We partner with carefully chosen global healthcare leaders to create best-in-class products using our patented microwave generator platform technology. Our partners can take advantage of a rapid product development capability, an agile and responsive team, and the potential for a streamlined regulatory submission – resulting in a significantly faster time to market.